The implications for neural-level insulin resistance and MDD are clear considering findings that obese humans show neural unresponsiveness to exogenous insulin [22] and fail to show mood elevating effects [23] observed in normal-weight humans resulting from a course of intranasal insulin administration [24]. The gene discussed is INS; the disease is Insulin resistance.